Rilpivirine hydrochloride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rilpivirine hydrochloride, covering 2025-12-09 to 2025-12-09. Get the full timeline:
Most recent: EMA Authorised: Eviplera (emtricitabine;rilpivirine hydrochloride;tenofovir disoproxil fumarate) — Gilead Sciences International Ltd